Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 0.24% |
$1,115,500
$44.62 p/Share
|
Jul 18
2018 |
|
IDSY
|
Cannell Capital LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,600 Added 0.12% |
$15,756
$6.06 p/Share
|
Jul 18
2018 |
|
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,300 Added 0.13% |
$82,566
$25.02 p/Share
|
Jul 18
2018 |
|
CSSE
|
Greenhaven Road Investment Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,900 Added 0.7% |
$37,011
$9.49 p/Share
|
Jul 18
2018 |
|
MNI
|
Chatham Asset Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.47% |
$51,550
$10.31 p/Share
|
Jul 18
2018 |
|
EGN
|
Icahn Carl C |
BUY
Open market or private purchase
|
Indirect | 1,200 Added 0.02% |
$87,336
$72.78 p/Share
|
Jul 17
2018 |
|
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 600 Added 0.02% |
$15,510
$25.85 p/Share
|
Jul 17
2018 |
|
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 0.24% |
$1,114,250
$44.57 p/Share
|
Jul 17
2018 |
|
SPRO
|
Glaxosmithkline PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 80,000 Added 3.97% |
$1,000,000
$12.5 p/Share
|
Jul 17
2018 |
|
CHCO
|
Robert D Fisher
Director |
BUY
Open market or private purchase
|
Direct | 132 Added 0.42% |
$10,068
$76.27 p/Share
|
Jul 17
2018 |
|
CHCO
|
Tracy W Hylton Ii
Director |
BUY
Open market or private purchase
|
Direct | 141 Added 0.3% |
$10,754
$76.27 p/Share
|
Jul 17
2018 |
|
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 9,719 Added 0.06% |
$41,792
$4.3 p/Share
|
Jul 17
2018 |
|
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Jul 17
2018 |
|
IFF
|
Winder Investment Pte LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 46,400 Added 0.33% |
$5,961,936
$128.49 p/Share
|
Jul 17
2018 |
|
STKS
|
David Kanen
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,822 Added 0.16% |
$12,296
$2.55 p/Share
|
Jul 17
2018 |
|
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 518 Added 0.0% |
$3,626
$7.0 p/Share
|
Jul 17
2018 |
|
SHSP
|
Cat Rock Capital Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 40,859 Added 4.18% |
$469,878
$11.5 p/Share
|
Jul 17
2018 |
|
CSSE
|
Greenhaven Road Investment Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,000 Added 0.55% |
$28,050
$9.35 p/Share
|
Jul 17
2018 |
|
ACOR
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 8,199 Reduced 0.11% |
$246,380
$30.05 p/Share
|
Jul 17
2018 |
|
LGF-B
|
John C Malone
Director |
SELL
Open market or private sale
|
Indirect | 23,631 Reduced 24.27% |
$558,164
$23.62 p/Share
|
Jul 17
2018 |
|
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 0.49% |
$58,875
$4.71 p/Share
|
Jul 17
2018 |
|
SDOI
|
Standard General L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,900 Reduced 0.04% |
$40,513
$13.97 p/Share
|
Jul 17
2018 |
|
EPE
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 395,420 Reduced 0.36% |
$929,237
$2.35 p/Share
|
Jul 17
2018 |
|
PNC
|
Steven C. Van Wyk
Executive Vice President |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 55.58% |
$2,116,350
$141.09 p/Share
|
Jul 17
2018 |
|
PNC
|
Michael J Hannon
Executive Vice President |
SELL
Open market or private sale
|
Direct | 5,247 Reduced 8.26% |
$741,821
$141.38 p/Share
|
Jul 17
2018 |
|
DJCO
|
John Patrick Et Al Guerin
Director |
SELL
Open market or private sale
|
Indirect | 1 Reduced 0.0% |
$236
$236.0 p/Share
|
Jul 16
2018 |
|
AMGN
|
Sean E Harper
EVP, Research & Development |
SELL
Open market or private sale
|
Direct | 1,525 Reduced 2.65% |
$298,458
$195.71 p/Share
|
Jul 16
2018 |
|
AROW
|
Raymond F O'Conor
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.06% |
$18,750
$37.5 p/Share
|
Jul 16
2018 |
|
ACOR
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 0.34% |
$751,000
$30.04 p/Share
|
Jul 16
2018 |
|
PFE
|
Ian C Read
Executive Chairman |
SELL
Open market or private sale
|
Direct | 486,753 Reduced 42.47% |
$18,214,296
$37.42 p/Share
|
Jul 16
2018 |
|
ORCL
|
Naomi O Seligman
Director |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 62.2% |
$2,164,050
$48.09 p/Share
|
Jul 16
2018 |
|
ORCL
|
Hector Garcia Molina
Director |
SELL
Open market or private sale
|
Direct | 3,750 Reduced 12.57% |
$180,938
$48.25 p/Share
|
Jul 16
2018 |
|
LGF-B
|
John C Malone
Director |
SELL
Open market or private sale
|
Indirect | 13,369 Reduced 12.07% |
$320,455
$23.97 p/Share
|
Jul 16
2018 |
|
EVBG
|
Kenneth S Goldman
SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 815 Reduced 11.5% |
$40,709
$49.95 p/Share
|
Jul 16
2018 |
|
AVGO
|
Hock E Tan
President and CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 15.4% |
$4,052,000
$202.6 p/Share
|
Jul 16
2018 |
|
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.01% |
$1,545
$5.15 p/Share
|
Jul 16
2018 |
|
EFSC
|
Scott Richard Goodman
President |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 2.8% |
$65,076
$54.23 p/Share
|
Jul 16
2018 |
|
SDOI
|
Standard General L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,700 Reduced 0.02% |
$23,800
$14.0 p/Share
|
Jul 16
2018 |
|
EPE
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 338,581 Reduced 0.31% |
$832,909
$2.46 p/Share
|
Jul 16
2018 |
|
WLY
|
Deborah E Wiley
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 89 Added 0.0% |
$5,933
$66.67 p/Share
|
Jul 16
2018 |
|
APTS
|
Steve Bartkowski |
BUY
Open market or private purchase
|
Direct | 658 Added 0.79% |
$11,528
$17.52 p/Share
|
Jul 16
2018 |
|
EGN
|
Icahn Carl C |
BUY
Open market or private purchase
|
Indirect | 600 Added 0.01% |
$44,190
$73.65 p/Share
|
Jul 16
2018 |
|
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 43,191 Added 0.23% |
$301,905
$6.99 p/Share
|
Jul 16
2018 |
|
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 58,682 Added 0.56% |
$2,617,804
$44.61 p/Share
|
Jul 16
2018 |
|
IFF
|
Winder Investment Pte LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 77,000 Added 0.54% |
$9,824,430
$127.59 p/Share
|
Jul 16
2018 |
|
TDF
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,630 Added 0.73% |
$118,511
$21.05 p/Share
|
Jul 16
2018 |
|
GABC
|
Marc D Fine |
BUY
Open market or private purchase
|
Direct | 138 Added 0.37% |
$4,991
$36.17 p/Share
|
Jul 16
2018 |
|
GABC
|
Raymond Ward Snowden |
BUY
Open market or private purchase
|
Indirect | 553 Added 1.93% |
$20,002
$36.17 p/Share
|
Jul 16
2018 |
|
GABC
|
Chris A Ramsey |
BUY
Open market or private purchase
|
Direct | 553 Added 3.0% |
$20,002
$36.17 p/Share
|
Jul 16
2018 |
|
GABC
|
Thomas W Seger |
BUY
Open market or private purchase
|
Indirect | 553 Added 0.17% |
$20,002
$36.17 p/Share
|
Jul 16
2018 |